Nasdaq:regn lawsuit notice: investors who hold shares of regeneron pharmaceuticals, inc. (nasdaq:regn) should contact the shareholders foundation

A lawsuit was filed for certain investors in regeneron pharmaceuticals, inc. (nasdaq:regn) shares. investors who purchased shares of regeneron pharmaceuticals, inc. (nasdaq:regn) and continue to hold any of those nasdaq:regn shares, should contact the shareholders foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
REGN Ratings Summary
REGN Quant Ranking